Regulatory & Reimbursement
CMS Mandatory ESRD Model Looks to Accelerate Home Dialysis and Kidney Transplants
The agency’s End-Stage Renal Disease Treatment Choices (ETC) Model, set to launch January 1, will impact approximately 30% of kidney care providers for an estimated $23 million cost savings over the next few years. David White of the American Society of Nephrology discusses the model’s positives and challenges, particularly with the added impact of COVID-19.
Read Article